Wenrui Duan joined HWCOM in October of 2016 and leads the Duan Lab. He was previously a research scientist at the Comprehensive Cancer Center of the Ohio State University (OSUCCC), and a research oriented assistant professor in the Division of Medical Oncology, College of Medicine at Ohio State University.
Duan’s research interests include cancer genetics, the development of cell and animal models for targeted therapy in cancers. He is also interested in the development of novel biomarkers for the identification of subgroups of patients who are most likely to respond to treatment of novel anticancer agents. Duan has been involved in several universities, foundations, States, and NIH-funded research projects as both a principal investigator and co-investigator.